| Financial Year |
March 31 2023 |
| Monetary Funds |
810,930,060.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
132,940,610.42 |
| Accounts Receivable |
340,278,121.31 |
| Advances to Suppliers |
48,491,078.67 |
| Other Receivables |
26,593,025.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
606,619,484.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,488,336.47 |
| Total Current Assets |
1,997,518,871.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
22,717,930.97 |
| Investment Properties |
-- |
| Fixed Assetes |
1,888,271,226.97 |
| Under-construction Projects |
260,646,480.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,723,948,634.30 |
| R&D expenses |
273,007,250.61 |
| Goodwill |
157,026,145.50 |
| Long-Term Deferred and Prepaid Expenses |
45,380,314.74 |
| Deferred Income Tax Assets |
78,109,884.43 |
| Other Non-Current Assets |
8,294,300.83 |
| Sub-Total of Non-Current Assets |
4,457,402,168.86 |
| Total Assets |
6,454,921,040.73 |
| Short-Term Loans |
400,000,000.00 |
| Trading Financial liabilities |
249,462,851.79 |
| Notes Payable |
-- |
| Accounts Payable |
209,783,908.86 |
| Accounts Received In Advance |
104,952.56 |
| Employee Compensation Payable |
38,455,478.57 |
| Taxes Payable |
24,769,844.87 |
| Interest Payable |
380,935.70 |
| Dividend Payable |
-- |
| Other payables |
96,299,771.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
49,854,889.52 |
| Other Current Liabilities |
90,188,821.46 |
| Sub-Total of Current Liabilities |
1,161,011,378.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
168,829,073.60 |
| Special Payable |
-- |
| Estimatied Liabilities |
108,236,989.21 |
| Deferred Income Tax Liabilities |
233,557,423.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
596,015,855.31 |
| Total Liabilities |
1,757,027,234.17 |
| Paid-In Capital(Or Share Stock) |
922,853,531.00 |
| Capital Surplus |
2,663,845,895.21 |
| Surplus Reserve |
125,114,313.28 |
| LESS:Treasury Stock |
35,499,748.65 |
| Undistributed Profits |
1,018,628,899.39 |
| Minority Stockholder's Interest |
-857.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,697,894,663.64 |
| Owner's Equity（Stockholder's Equity） |
4,697,893,806.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,454,921,040.73 |
